Literature DB >> 17206507

Leishmania (Viannia) lainsoni (Silveira et al. 1987): ultrastructural aspects of the parasite and skin lesion in experimentally infected hamster (Mesocricetus auratus).

José R Corrêa1, Reginaldo P Brazil, Maurilio J Soares.   

Abstract

Leishmania (Viannia) lainsoni was first described in 1987 in the state of Pará, in the Brazilian Amazon region. The initial characterization of this parasite was performed based only in light microscopy techniques. Posterior studies with this Leishmania species, which focused on biochemistry and molecular assays, showed its divergent position in the Leishmania genus. In this study, we characterize the ultrastructure of culture promastigote forms throughout the growth curve. Our results demonstrate a time-dependent accumulation of electron-dense deposit in the acidocalcisome matrix. We have also analyzed, by transmission electron microscopy, the chronic experimental skin lesion induced in hamster. The experimental infection assay showed adhesion of the intracellular parasites to the parasitophorous vacuole membrane and the occurrence of free vacuoles in the lesion site containing amastigote forms (the amastigote forms morphometrical data were summarized). Our morphological evidences suggest a possible alternative surviving mechanism for L. (Viannia) lainsoni in chronic lesion site.

Entities:  

Mesh:

Year:  2007        PMID: 17206507     DOI: 10.1007/s00436-006-0395-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  25 in total

1.  An oligonucleotide probe derived from kDNA minirepeats is specific for Leishmania (Viannia).

Authors:  O Fernandes; M Bozza; J M Pascale; A B de Miranda; U G Lopes; W M Degrave
Journal:  Mem Inst Oswaldo Cruz       Date:  1996 May-Jun       Impact factor: 2.743

Review 2.  Leishmania (Viannia) lainsoni (Kinetoplastida: Trypanosomatidae), a divergent Leishmania of the Viannia subgenus--a mini review.

Authors:  José R Corrêa; Reginaldo P Brazil; Maurilio J Soares
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-11-08       Impact factor: 2.743

3.  [Experimental cutaneous leishmaniasis. III. Histopathological aspects of the developmental behavior of the cutaneous lesion induced in Cebus apella (Primates: Cebidae) by Leishmania (Viannia) lainsoni, L. (V.) braziliensis and L. (Leishmania) amazonensis].

Authors:  F T Silveira; M A Moraes; R Lainson; J J Shaw
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1990 Nov-Dec       Impact factor: 1.846

Review 4.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

5.  Axenic promastigote forms of Leishmania (Viannia) lainsoni as an alternative source for Leishmania antigen production.

Authors:  José R Corrêa; Sidney G Santos; Márcio S Araújo; Cibele Baptista; Maurilio J Soares; Reginaldo P Brazil
Journal:  J Parasitol       Date:  2005-06       Impact factor: 1.276

6.  First evidence of transmission of Leishmania (Viannia) lainsoni in a Sub Andean region of Bolivia.

Authors:  B Bastrenta; R Buitrago; F Vargas; F Le Pont; M Torrez; M Flores; N Mita; S F Brenière
Journal:  Acta Trop       Date:  2002-09       Impact factor: 3.112

7.  Immunopathology of experimental cutaneous leishmaniasis.

Authors:  Z A Andrade; S G Reed; S B Roters; M Sadigursky
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

Review 8.  Leishmaniasis.

Authors:  T G Evans
Journal:  Infect Dis Clin North Am       Date:  1993-09       Impact factor: 5.982

9.  Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis.

Authors:  G Grimaldi; M J Soares; P L Moriearty
Journal:  Parasite Immunol       Date:  1984-09       Impact factor: 2.280

10.  Dermal leishmaniasis in the Amazon region of Brazil: Leishmania (Viannaia) lainsoni sp.n., a new parasite from the State of Pará.

Authors:  F T Silveira; J J Shaw; R R Braga; E Ishikawa
Journal:  Mem Inst Oswaldo Cruz       Date:  1987 Apr-Jun       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.